Marc Salzberg
Chief Executive Officer at Airway Therapeutics, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Norbert Eller | M | - |
Denothex AG
Denothex AG Miscellaneous Commercial ServicesCommercial Services Denothex AG operates as a boutique clinical research organization. It manages clinical trials of all phases across Europe and Israel, with particular focus on biotechnology and medical devices in oncology. The company was founded by Norbert Eller in 1998 and is headquartered in Ettingen, Switzerland. | 26 years |
Alan S. Wolk | M | - |
Airway Therapeutics, Inc.
Airway Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Airway Therapeutics, Inc. operates as a pharmaceutical company which specializes in the development of surfactant-related products. The firm offers products for the prevention of bronchopulmonary dysplasia, as well as for the treatment of pulmonary infections associated with cystic fibrosis. It also provides pediatric drug development, orphan drug development, pulmonary therapies, protein drug development, neonatal drug therapy, and inhalation drug delivery. The company was founded by Charles McOsker in 2011 and is headquartered in Cincinnati, OH. | - |
E. Panayotopoulos | M | 71 |
Airway Therapeutics, Inc.
Airway Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Airway Therapeutics, Inc. operates as a pharmaceutical company which specializes in the development of surfactant-related products. The firm offers products for the prevention of bronchopulmonary dysplasia, as well as for the treatment of pulmonary infections associated with cystic fibrosis. It also provides pediatric drug development, orphan drug development, pulmonary therapies, protein drug development, neonatal drug therapy, and inhalation drug delivery. The company was founded by Charles McOsker in 2011 and is headquartered in Cincinnati, OH. | 4 years |
Jennifer Dauer | F | - |
Airway Therapeutics, Inc.
Airway Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Airway Therapeutics, Inc. operates as a pharmaceutical company which specializes in the development of surfactant-related products. The firm offers products for the prevention of bronchopulmonary dysplasia, as well as for the treatment of pulmonary infections associated with cystic fibrosis. It also provides pediatric drug development, orphan drug development, pulmonary therapies, protein drug development, neonatal drug therapy, and inhalation drug delivery. The company was founded by Charles McOsker in 2011 and is headquartered in Cincinnati, OH. | - |
John M. Rice | M | 74 |
Airway Therapeutics, Inc.
Airway Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Airway Therapeutics, Inc. operates as a pharmaceutical company which specializes in the development of surfactant-related products. The firm offers products for the prevention of bronchopulmonary dysplasia, as well as for the treatment of pulmonary infections associated with cystic fibrosis. It also provides pediatric drug development, orphan drug development, pulmonary therapies, protein drug development, neonatal drug therapy, and inhalation drug delivery. The company was founded by Charles McOsker in 2011 and is headquartered in Cincinnati, OH. | 13 years |
Angelo Riccaboni | M | - |
University of Milano-Bicocca
| - |
Michael P. Venerable | M | 61 |
Airway Therapeutics, Inc.
Airway Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Airway Therapeutics, Inc. operates as a pharmaceutical company which specializes in the development of surfactant-related products. The firm offers products for the prevention of bronchopulmonary dysplasia, as well as for the treatment of pulmonary infections associated with cystic fibrosis. It also provides pediatric drug development, orphan drug development, pulmonary therapies, protein drug development, neonatal drug therapy, and inhalation drug delivery. The company was founded by Charles McOsker in 2011 and is headquartered in Cincinnati, OH. | - |
Jan S. Rosenbaum | M | - |
Airway Therapeutics, Inc.
Airway Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Airway Therapeutics, Inc. operates as a pharmaceutical company which specializes in the development of surfactant-related products. The firm offers products for the prevention of bronchopulmonary dysplasia, as well as for the treatment of pulmonary infections associated with cystic fibrosis. It also provides pediatric drug development, orphan drug development, pulmonary therapies, protein drug development, neonatal drug therapy, and inhalation drug delivery. The company was founded by Charles McOsker in 2011 and is headquartered in Cincinnati, OH. | - |
Franco Confalonieri | M | 60 |
University of Milano-Bicocca
| - |
Francesca Pasinelli | F | 64 |
University of Milano-Bicocca
| - |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
United States | 6 | 60.00% |
Italy | 3 | 30.00% |
Switzerland | 1 | 10.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Marc Salzberg
- Personal Network